nodes	percent_of_prediction	percent_of_DWPC	metapath
Reboxetine—Phenprocoumon—Phenytoin—epilepsy syndrome	0.152	0.693	CrCrCtD
Reboxetine—SLC6A4—epilepsy syndrome	0.126	0.454	CbGaD
Reboxetine—CYP2D6—epilepsy syndrome	0.0889	0.319	CbGaD
Reboxetine—Diphenhydramine—Phenytoin—epilepsy syndrome	0.0673	0.307	CrCrCtD
Reboxetine—ABCB1—epilepsy syndrome	0.0635	0.228	CbGaD
Reboxetine—ABCB1—Levetiracetam—epilepsy syndrome	0.0231	0.0871	CbGbCtD
Reboxetine—ABCB1—Clobazam—epilepsy syndrome	0.016	0.0603	CbGbCtD
Reboxetine—ABCB1—Lamotrigine—epilepsy syndrome	0.0154	0.0581	CbGbCtD
Reboxetine—ABCB1—Carbamazepine—epilepsy syndrome	0.0133	0.05	CbGbCtD
Reboxetine—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0127	0.0477	CbGbCtD
Reboxetine—ABCB1—Phenytoin—epilepsy syndrome	0.0119	0.0448	CbGbCtD
Reboxetine—CYP3A4—Felbamate—epilepsy syndrome	0.0118	0.0443	CbGbCtD
Reboxetine—CYP3A4—Trimethadione—epilepsy syndrome	0.0118	0.0443	CbGbCtD
Reboxetine—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0111	0.0417	CbGbCtD
Reboxetine—ABCB1—Phenobarbital—epilepsy syndrome	0.0106	0.04	CbGbCtD
Reboxetine—ABCB1—Midazolam—epilepsy syndrome	0.0105	0.0394	CbGbCtD
Reboxetine—CYP2D6—Propofol—epilepsy syndrome	0.0105	0.0394	CbGbCtD
Reboxetine—ABCB1—Diazepam—epilepsy syndrome	0.01	0.0379	CbGbCtD
Reboxetine—CYP3A4—Clonazepam—epilepsy syndrome	0.01	0.0377	CbGbCtD
Reboxetine—CYP3A4—Clobazam—epilepsy syndrome	0.00959	0.0362	CbGbCtD
Reboxetine—CYP3A4—Rufinamide—epilepsy syndrome	0.00815	0.0307	CbGbCtD
Reboxetine—CYP3A4—Carbamazepine—epilepsy syndrome	0.00794	0.03	CbGbCtD
Reboxetine—CYP3A4—Primidone—epilepsy syndrome	0.00742	0.028	CbGbCtD
Reboxetine—CYP3A4—Phenytoin—epilepsy syndrome	0.00713	0.0269	CbGbCtD
Reboxetine—CYP3A4—Propofol—epilepsy syndrome	0.00665	0.0251	CbGbCtD
Reboxetine—CYP3A4—Acetazolamide—epilepsy syndrome	0.00635	0.0239	CbGbCtD
Reboxetine—CYP3A4—Phenobarbital—epilepsy syndrome	0.00635	0.0239	CbGbCtD
Reboxetine—CYP3A4—Midazolam—epilepsy syndrome	0.00626	0.0236	CbGbCtD
Reboxetine—CYP3A4—Diazepam—epilepsy syndrome	0.00602	0.0227	CbGbCtD
Reboxetine—CYP3A4—Zonisamide—epilepsy syndrome	0.00588	0.0222	CbGbCtD
Reboxetine—CYP3A4—Valproic Acid—epilepsy syndrome	0.00475	0.0179	CbGbCtD
Reboxetine—CYP3A4—Topiramate—epilepsy syndrome	0.00428	0.0161	CbGbCtD
Reboxetine—SLC6A2—locus ceruleus—epilepsy syndrome	0.00416	0.146	CbGeAlD
Reboxetine—HTR2C—telencephalic ventricle—epilepsy syndrome	0.00236	0.0827	CbGeAlD
Reboxetine—SLC6A2—autonomic nervous system—epilepsy syndrome	0.00221	0.0774	CbGeAlD
Reboxetine—HTR2C—ganglion—epilepsy syndrome	0.00147	0.0515	CbGeAlD
Reboxetine—SLC6A4—ganglion—epilepsy syndrome	0.00139	0.0488	CbGeAlD
Reboxetine—SLC6A2—ganglion—epilepsy syndrome	0.00123	0.043	CbGeAlD
Reboxetine—SLC6A4—hindbrain—epilepsy syndrome	0.00106	0.037	CbGeAlD
Reboxetine—HTR2C—brainstem—epilepsy syndrome	0.000639	0.0224	CbGeAlD
Reboxetine—HTR2C—forebrain—epilepsy syndrome	0.000617	0.0216	CbGeAlD
Reboxetine—SLC6A4—brainstem—epilepsy syndrome	0.000606	0.0212	CbGeAlD
Reboxetine—SLC6A4—forebrain—epilepsy syndrome	0.000585	0.0205	CbGeAlD
Reboxetine—HTR2C—telencephalon—epilepsy syndrome	0.000567	0.0199	CbGeAlD
Reboxetine—SLC6A4—telencephalon—epilepsy syndrome	0.000538	0.0188	CbGeAlD
Reboxetine—SLC6A2—brainstem—epilepsy syndrome	0.000533	0.0187	CbGeAlD
Reboxetine—SLC6A2—forebrain—epilepsy syndrome	0.000515	0.018	CbGeAlD
Reboxetine—CYP2D6—hindbrain—epilepsy syndrome	0.00051	0.0178	CbGeAlD
Reboxetine—SLC6A2—telencephalon—epilepsy syndrome	0.000473	0.0166	CbGeAlD
Reboxetine—HTR2C—medulla oblongata—epilepsy syndrome	0.000446	0.0156	CbGeAlD
Reboxetine—HTR2C—midbrain—epilepsy syndrome	0.000407	0.0143	CbGeAlD
Reboxetine—HTR2C—spinal cord—epilepsy syndrome	0.000397	0.0139	CbGeAlD
Reboxetine—SLC6A4—midbrain—epilepsy syndrome	0.000386	0.0135	CbGeAlD
Reboxetine—SLC6A4—spinal cord—epilepsy syndrome	0.000377	0.0132	CbGeAlD
Reboxetine—SLC6A2—medulla oblongata—epilepsy syndrome	0.000372	0.013	CbGeAlD
Reboxetine—HTR2C—head—epilepsy syndrome	0.000353	0.0124	CbGeAlD
Reboxetine—HTR2C—nervous system—epilepsy syndrome	0.000335	0.0117	CbGeAlD
Reboxetine—SLC6A4—head—epilepsy syndrome	0.000335	0.0117	CbGeAlD
Reboxetine—Orphenadrine—SCN9A—epilepsy syndrome	0.000327	0.138	CrCbGaD
Reboxetine—HTR2C—central nervous system—epilepsy syndrome	0.000322	0.0113	CbGeAlD
Reboxetine—SLC6A4—nervous system—epilepsy syndrome	0.000317	0.0111	CbGeAlD
Reboxetine—SLC6A4—central nervous system—epilepsy syndrome	0.000306	0.0107	CbGeAlD
Reboxetine—Orphenadrine—SCN4A—epilepsy syndrome	0.0003	0.127	CrCbGaD
Reboxetine—SLC6A2—head—epilepsy syndrome	0.000295	0.0103	CbGeAlD
Reboxetine—CYP2D6—brainstem—epilepsy syndrome	0.000292	0.0102	CbGeAlD
Reboxetine—CYP2D6—forebrain—epilepsy syndrome	0.000282	0.00987	CbGeAlD
Reboxetine—Benzatropine—CHRM1—epilepsy syndrome	0.000281	0.119	CrCbGaD
Reboxetine—SLC6A2—nervous system—epilepsy syndrome	0.000279	0.00979	CbGeAlD
Reboxetine—SLC6A2—central nervous system—epilepsy syndrome	0.000269	0.00942	CbGeAlD
Reboxetine—CYP2D6—telencephalon—epilepsy syndrome	0.000259	0.00908	CbGeAlD
Reboxetine—HTR2C—brain—epilepsy syndrome	0.000256	0.00896	CbGeAlD
Reboxetine—SLC6A4—brain—epilepsy syndrome	0.000243	0.0085	CbGeAlD
Reboxetine—Benzatropine—CHRM2—epilepsy syndrome	0.000229	0.097	CrCbGaD
Reboxetine—Orphenadrine—SCN1A—epilepsy syndrome	0.000219	0.0927	CrCbGaD
Reboxetine—SLC6A2—brain—epilepsy syndrome	0.000214	0.00748	CbGeAlD
Reboxetine—ABCB1—forebrain—epilepsy syndrome	0.000203	0.0071	CbGeAlD
Reboxetine—ABCB1—telencephalon—epilepsy syndrome	0.000186	0.00653	CbGeAlD
Reboxetine—CYP2D6—head—epilepsy syndrome	0.000161	0.00565	CbGeAlD
Reboxetine—CYP3A4—nervous system—epilepsy syndrome	0.000155	0.00545	CbGeAlD
Reboxetine—CYP2D6—nervous system—epilepsy syndrome	0.000153	0.00536	CbGeAlD
Reboxetine—CYP3A4—central nervous system—epilepsy syndrome	0.00015	0.00524	CbGeAlD
Reboxetine—CYP2D6—central nervous system—epilepsy syndrome	0.000147	0.00516	CbGeAlD
Reboxetine—ABCB1—medulla oblongata—epilepsy syndrome	0.000146	0.00513	CbGeAlD
Reboxetine—CYP2D6—cerebellum—epilepsy syndrome	0.000144	0.00504	CbGeAlD
Reboxetine—Benzatropine—CYP2C19—epilepsy syndrome	0.000142	0.0599	CrCbGaD
Reboxetine—ABCB1—midbrain—epilepsy syndrome	0.000134	0.00469	CbGeAlD
Reboxetine—ABCB1—spinal cord—epilepsy syndrome	0.000131	0.00458	CbGeAlD
Reboxetine—Diphenhydramine—CHRM2—epilepsy syndrome	0.000118	0.0499	CrCbGaD
Reboxetine—CYP2D6—brain—epilepsy syndrome	0.000117	0.0041	CbGeAlD
Reboxetine—ABCB1—head—epilepsy syndrome	0.000116	0.00407	CbGeAlD
Reboxetine—Orphenadrine—CHRM2—epilepsy syndrome	0.000112	0.0472	CrCbGaD
Reboxetine—ABCB1—nervous system—epilepsy syndrome	0.00011	0.00386	CbGeAlD
Reboxetine—ABCB1—central nervous system—epilepsy syndrome	0.000106	0.00371	CbGeAlD
Reboxetine—Benzatropine—CYP2D6—epilepsy syndrome	0.000105	0.0444	CrCbGaD
Reboxetine—ABCB1—cerebellum—epilepsy syndrome	0.000104	0.00363	CbGeAlD
Reboxetine—Atomoxetine—SLC6A4—epilepsy syndrome	9.51e-05	0.0402	CrCbGaD
Reboxetine—Atomoxetine—CYP2C19—epilepsy syndrome	9.02e-05	0.0381	CrCbGaD
Reboxetine—ABCB1—brain—epilepsy syndrome	8.41e-05	0.00295	CbGeAlD
Reboxetine—Phenprocoumon—ALB—epilepsy syndrome	8e-05	0.0338	CrCbGaD
Reboxetine—Atomoxetine—HTR2A—epilepsy syndrome	7.31e-05	0.0309	CrCbGaD
Reboxetine—Diphenhydramine—CYP2C19—epilepsy syndrome	7.28e-05	0.0308	CrCbGaD
Reboxetine—Atomoxetine—CYP2D6—epilepsy syndrome	6.69e-05	0.0283	CrCbGaD
Reboxetine—Diphenhydramine—CYP2D6—epilepsy syndrome	5.4e-05	0.0228	CrCbGaD
Reboxetine—Dermatitis—Fosphenytoin—epilepsy syndrome	3.56e-05	0.000213	CcSEcCtD
Reboxetine—Nervousness—Gabapentin—epilepsy syndrome	3.56e-05	0.000213	CcSEcCtD
Reboxetine—Asthenia—Clonazepam—epilepsy syndrome	3.55e-05	0.000213	CcSEcCtD
Reboxetine—Rhinitis—Topiramate—epilepsy syndrome	3.55e-05	0.000213	CcSEcCtD
Reboxetine—Headache—Fosphenytoin—epilepsy syndrome	3.54e-05	0.000212	CcSEcCtD
Reboxetine—Nervous system disorder—Valproic Acid—epilepsy syndrome	3.54e-05	0.000212	CcSEcCtD
Reboxetine—Palpitations—Pregabalin—epilepsy syndrome	3.53e-05	0.000212	CcSEcCtD
Reboxetine—Asthenia—Phenytoin—epilepsy syndrome	3.53e-05	0.000212	CcSEcCtD
Reboxetine—Nausea—Midazolam—epilepsy syndrome	3.52e-05	0.000211	CcSEcCtD
Reboxetine—Hallucination—Topiramate—epilepsy syndrome	3.52e-05	0.000211	CcSEcCtD
Reboxetine—Tachycardia—Valproic Acid—epilepsy syndrome	3.52e-05	0.000211	CcSEcCtD
Reboxetine—Diarrhoea—Zonisamide—epilepsy syndrome	3.52e-05	0.000211	CcSEcCtD
Reboxetine—Pharyngitis—Topiramate—epilepsy syndrome	3.51e-05	0.000211	CcSEcCtD
Reboxetine—Loss of consciousness—Pregabalin—epilepsy syndrome	3.51e-05	0.00021	CcSEcCtD
Reboxetine—Asthenia—Oxcarbazepine—epilepsy syndrome	3.51e-05	0.00021	CcSEcCtD
Reboxetine—Vomiting—Vigabatrin—epilepsy syndrome	3.5e-05	0.00021	CcSEcCtD
Reboxetine—Skin disorder—Valproic Acid—epilepsy syndrome	3.5e-05	0.00021	CcSEcCtD
Reboxetine—Urinary tract disorder—Topiramate—epilepsy syndrome	3.5e-05	0.00021	CcSEcCtD
Reboxetine—Hyperhidrosis—Valproic Acid—epilepsy syndrome	3.49e-05	0.000209	CcSEcCtD
Reboxetine—Connective tissue disorder—Topiramate—epilepsy syndrome	3.48e-05	0.000209	CcSEcCtD
Reboxetine—Nausea—Levetiracetam—epilepsy syndrome	3.48e-05	0.000209	CcSEcCtD
Reboxetine—Rash—Vigabatrin—epilepsy syndrome	3.47e-05	0.000208	CcSEcCtD
Reboxetine—Dizziness—Felbamate—epilepsy syndrome	3.47e-05	0.000208	CcSEcCtD
Reboxetine—Dermatitis—Vigabatrin—epilepsy syndrome	3.47e-05	0.000208	CcSEcCtD
Reboxetine—Urethral disorder—Topiramate—epilepsy syndrome	3.47e-05	0.000208	CcSEcCtD
Reboxetine—Hypersensitivity—Carbamazepine—epilepsy syndrome	3.46e-05	0.000207	CcSEcCtD
Reboxetine—Headache—Vigabatrin—epilepsy syndrome	3.45e-05	0.000207	CcSEcCtD
Reboxetine—Hypertension—Pregabalin—epilepsy syndrome	3.45e-05	0.000207	CcSEcCtD
Reboxetine—Vomiting—Diazepam—epilepsy syndrome	3.45e-05	0.000207	CcSEcCtD
Reboxetine—Anorexia—Valproic Acid—epilepsy syndrome	3.44e-05	0.000206	CcSEcCtD
Reboxetine—Tremor—Gabapentin—epilepsy syndrome	3.43e-05	0.000206	CcSEcCtD
Reboxetine—Rash—Diazepam—epilepsy syndrome	3.42e-05	0.000205	CcSEcCtD
Reboxetine—Dermatitis—Diazepam—epilepsy syndrome	3.42e-05	0.000205	CcSEcCtD
Reboxetine—Visual impairment—Topiramate—epilepsy syndrome	3.41e-05	0.000205	CcSEcCtD
Reboxetine—Chest pain—Pregabalin—epilepsy syndrome	3.4e-05	0.000204	CcSEcCtD
Reboxetine—Ill-defined disorder—Gabapentin—epilepsy syndrome	3.4e-05	0.000204	CcSEcCtD
Reboxetine—Dizziness—Zonisamide—epilepsy syndrome	3.4e-05	0.000204	CcSEcCtD
Reboxetine—Headache—Diazepam—epilepsy syndrome	3.4e-05	0.000204	CcSEcCtD
Reboxetine—Anxiety—Pregabalin—epilepsy syndrome	3.39e-05	0.000203	CcSEcCtD
Reboxetine—Diarrhoea—Clonazepam—epilepsy syndrome	3.39e-05	0.000203	CcSEcCtD
Reboxetine—Anaemia—Gabapentin—epilepsy syndrome	3.39e-05	0.000203	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	3.38e-05	0.000202	CcSEcCtD
Reboxetine—Hypotension—Valproic Acid—epilepsy syndrome	3.37e-05	0.000202	CcSEcCtD
Reboxetine—Asthenia—Carbamazepine—epilepsy syndrome	3.37e-05	0.000202	CcSEcCtD
Reboxetine—Agitation—Gabapentin—epilepsy syndrome	3.37e-05	0.000202	CcSEcCtD
Reboxetine—Diarrhoea—Phenytoin—epilepsy syndrome	3.37e-05	0.000202	CcSEcCtD
Reboxetine—Discomfort—Pregabalin—epilepsy syndrome	3.36e-05	0.000201	CcSEcCtD
Reboxetine—Nausea—Fosphenytoin—epilepsy syndrome	3.36e-05	0.000201	CcSEcCtD
Reboxetine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	3.35e-05	0.000201	CcSEcCtD
Reboxetine—Hypersensitivity—Lamotrigine—epilepsy syndrome	3.34e-05	0.0002	CcSEcCtD
Reboxetine—Vomiting—Felbamate—epilepsy syndrome	3.34e-05	0.0002	CcSEcCtD
Reboxetine—Dry mouth—Pregabalin—epilepsy syndrome	3.33e-05	0.000199	CcSEcCtD
Reboxetine—Rash—Felbamate—epilepsy syndrome	3.31e-05	0.000198	CcSEcCtD
Reboxetine—Eye disorder—Topiramate—epilepsy syndrome	3.31e-05	0.000198	CcSEcCtD
Reboxetine—Dermatitis—Felbamate—epilepsy syndrome	3.31e-05	0.000198	CcSEcCtD
Reboxetine—Malaise—Gabapentin—epilepsy syndrome	3.3e-05	0.000198	CcSEcCtD
Reboxetine—Tinnitus—Topiramate—epilepsy syndrome	3.3e-05	0.000198	CcSEcCtD
Reboxetine—Vertigo—Gabapentin—epilepsy syndrome	3.29e-05	0.000197	CcSEcCtD
Reboxetine—Headache—Felbamate—epilepsy syndrome	3.29e-05	0.000197	CcSEcCtD
Reboxetine—Confusional state—Pregabalin—epilepsy syndrome	3.29e-05	0.000197	CcSEcCtD
Reboxetine—Cardiac disorder—Topiramate—epilepsy syndrome	3.29e-05	0.000197	CcSEcCtD
Reboxetine—Syncope—Gabapentin—epilepsy syndrome	3.29e-05	0.000197	CcSEcCtD
Reboxetine—Leukopenia—Gabapentin—epilepsy syndrome	3.28e-05	0.000197	CcSEcCtD
Reboxetine—Dizziness—Clonazepam—epilepsy syndrome	3.28e-05	0.000196	CcSEcCtD
Reboxetine—Nausea—Vigabatrin—epilepsy syndrome	3.27e-05	0.000196	CcSEcCtD
Reboxetine—Vomiting—Zonisamide—epilepsy syndrome	3.27e-05	0.000196	CcSEcCtD
Reboxetine—Insomnia—Valproic Acid—epilepsy syndrome	3.26e-05	0.000196	CcSEcCtD
Reboxetine—Asthenia—Lamotrigine—epilepsy syndrome	3.26e-05	0.000195	CcSEcCtD
Reboxetine—Dizziness—Phenytoin—epilepsy syndrome	3.25e-05	0.000195	CcSEcCtD
Reboxetine—Rash—Zonisamide—epilepsy syndrome	3.24e-05	0.000194	CcSEcCtD
Reboxetine—Infection—Pregabalin—epilepsy syndrome	3.24e-05	0.000194	CcSEcCtD
Reboxetine—Paraesthesia—Valproic Acid—epilepsy syndrome	3.24e-05	0.000194	CcSEcCtD
Reboxetine—Palpitations—Gabapentin—epilepsy syndrome	3.24e-05	0.000194	CcSEcCtD
Reboxetine—Dermatitis—Zonisamide—epilepsy syndrome	3.24e-05	0.000194	CcSEcCtD
Reboxetine—Dizziness—Oxcarbazepine—epilepsy syndrome	3.24e-05	0.000194	CcSEcCtD
Reboxetine—Nausea—Diazepam—epilepsy syndrome	3.22e-05	0.000193	CcSEcCtD
Reboxetine—Loss of consciousness—Gabapentin—epilepsy syndrome	3.22e-05	0.000193	CcSEcCtD
Reboxetine—Headache—Zonisamide—epilepsy syndrome	3.22e-05	0.000193	CcSEcCtD
Reboxetine—Dyspnoea—Valproic Acid—epilepsy syndrome	3.22e-05	0.000193	CcSEcCtD
Reboxetine—Diarrhoea—Carbamazepine—epilepsy syndrome	3.21e-05	0.000193	CcSEcCtD
Reboxetine—Angiopathy—Topiramate—epilepsy syndrome	3.21e-05	0.000193	CcSEcCtD
Reboxetine—Shock—Pregabalin—epilepsy syndrome	3.21e-05	0.000192	CcSEcCtD
Reboxetine—Somnolence—Valproic Acid—epilepsy syndrome	3.21e-05	0.000192	CcSEcCtD
Reboxetine—Immune system disorder—Topiramate—epilepsy syndrome	3.2e-05	0.000192	CcSEcCtD
Reboxetine—Nervous system disorder—Pregabalin—epilepsy syndrome	3.2e-05	0.000192	CcSEcCtD
Reboxetine—Mediastinal disorder—Topiramate—epilepsy syndrome	3.19e-05	0.000191	CcSEcCtD
Reboxetine—Tachycardia—Pregabalin—epilepsy syndrome	3.18e-05	0.000191	CcSEcCtD
Reboxetine—Chills—Topiramate—epilepsy syndrome	3.18e-05	0.00019	CcSEcCtD
Reboxetine—Dyspepsia—Valproic Acid—epilepsy syndrome	3.17e-05	0.00019	CcSEcCtD
Reboxetine—Skin disorder—Pregabalin—epilepsy syndrome	3.17e-05	0.00019	CcSEcCtD
Reboxetine—Hypertension—Gabapentin—epilepsy syndrome	3.16e-05	0.00019	CcSEcCtD
Reboxetine—Hyperhidrosis—Pregabalin—epilepsy syndrome	3.15e-05	0.000189	CcSEcCtD
Reboxetine—Vomiting—Clonazepam—epilepsy syndrome	3.15e-05	0.000189	CcSEcCtD
Reboxetine—Decreased appetite—Valproic Acid—epilepsy syndrome	3.13e-05	0.000188	CcSEcCtD
Reboxetine—Vomiting—Phenytoin—epilepsy syndrome	3.13e-05	0.000188	CcSEcCtD
Reboxetine—Rash—Clonazepam—epilepsy syndrome	3.12e-05	0.000187	CcSEcCtD
Reboxetine—Dermatitis—Clonazepam—epilepsy syndrome	3.12e-05	0.000187	CcSEcCtD
Reboxetine—Chest pain—Gabapentin—epilepsy syndrome	3.12e-05	0.000187	CcSEcCtD
Reboxetine—Nausea—Felbamate—epilepsy syndrome	3.12e-05	0.000187	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	3.11e-05	0.000187	CcSEcCtD
Reboxetine—Vomiting—Oxcarbazepine—epilepsy syndrome	3.11e-05	0.000187	CcSEcCtD
Reboxetine—Anxiety—Gabapentin—epilepsy syndrome	3.11e-05	0.000186	CcSEcCtD
Reboxetine—Anorexia—Pregabalin—epilepsy syndrome	3.11e-05	0.000186	CcSEcCtD
Reboxetine—Dizziness—Carbamazepine—epilepsy syndrome	3.11e-05	0.000186	CcSEcCtD
Reboxetine—Diarrhoea—Lamotrigine—epilepsy syndrome	3.11e-05	0.000186	CcSEcCtD
Reboxetine—Headache—Clonazepam—epilepsy syndrome	3.1e-05	0.000186	CcSEcCtD
Reboxetine—Rash—Phenytoin—epilepsy syndrome	3.1e-05	0.000186	CcSEcCtD
Reboxetine—Mental disorder—Topiramate—epilepsy syndrome	3.1e-05	0.000186	CcSEcCtD
Reboxetine—Dermatitis—Phenytoin—epilepsy syndrome	3.1e-05	0.000186	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	3.1e-05	0.000186	CcSEcCtD
Reboxetine—Rash—Oxcarbazepine—epilepsy syndrome	3.09e-05	0.000185	CcSEcCtD
Reboxetine—Constipation—Valproic Acid—epilepsy syndrome	3.08e-05	0.000185	CcSEcCtD
Reboxetine—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.08e-05	0.000185	CcSEcCtD
Reboxetine—Headache—Phenytoin—epilepsy syndrome	3.08e-05	0.000185	CcSEcCtD
Reboxetine—Malnutrition—Topiramate—epilepsy syndrome	3.08e-05	0.000185	CcSEcCtD
Reboxetine—Discomfort—Gabapentin—epilepsy syndrome	3.08e-05	0.000185	CcSEcCtD
Reboxetine—Headache—Oxcarbazepine—epilepsy syndrome	3.07e-05	0.000184	CcSEcCtD
Reboxetine—Nausea—Zonisamide—epilepsy syndrome	3.05e-05	0.000183	CcSEcCtD
Reboxetine—Dry mouth—Gabapentin—epilepsy syndrome	3.05e-05	0.000183	CcSEcCtD
Reboxetine—Hypotension—Pregabalin—epilepsy syndrome	3.05e-05	0.000183	CcSEcCtD
Reboxetine—Tension—Topiramate—epilepsy syndrome	3.02e-05	0.000181	CcSEcCtD
Reboxetine—Dysgeusia—Topiramate—epilepsy syndrome	3.02e-05	0.000181	CcSEcCtD
Reboxetine—Confusional state—Gabapentin—epilepsy syndrome	3.01e-05	0.000181	CcSEcCtD
Reboxetine—Dizziness—Lamotrigine—epilepsy syndrome	3e-05	0.00018	CcSEcCtD
Reboxetine—Nervousness—Topiramate—epilepsy syndrome	2.99e-05	0.000179	CcSEcCtD
Reboxetine—Vomiting—Carbamazepine—epilepsy syndrome	2.99e-05	0.000179	CcSEcCtD
Reboxetine—Feeling abnormal—Valproic Acid—epilepsy syndrome	2.97e-05	0.000178	CcSEcCtD
Reboxetine—Infection—Gabapentin—epilepsy syndrome	2.97e-05	0.000178	CcSEcCtD
Reboxetine—Rash—Carbamazepine—epilepsy syndrome	2.96e-05	0.000178	CcSEcCtD
Reboxetine—Dermatitis—Carbamazepine—epilepsy syndrome	2.96e-05	0.000177	CcSEcCtD
Reboxetine—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	2.95e-05	0.000177	CcSEcCtD
Reboxetine—Insomnia—Pregabalin—epilepsy syndrome	2.95e-05	0.000177	CcSEcCtD
Reboxetine—Nausea—Clonazepam—epilepsy syndrome	2.94e-05	0.000176	CcSEcCtD
Reboxetine—Headache—Carbamazepine—epilepsy syndrome	2.94e-05	0.000176	CcSEcCtD
Reboxetine—Shock—Gabapentin—epilepsy syndrome	2.94e-05	0.000176	CcSEcCtD
Reboxetine—Nervous system disorder—Gabapentin—epilepsy syndrome	2.93e-05	0.000176	CcSEcCtD
Reboxetine—Paraesthesia—Pregabalin—epilepsy syndrome	2.93e-05	0.000176	CcSEcCtD
Reboxetine—Nausea—Phenytoin—epilepsy syndrome	2.92e-05	0.000175	CcSEcCtD
Reboxetine—Tachycardia—Gabapentin—epilepsy syndrome	2.92e-05	0.000175	CcSEcCtD
Reboxetine—Dyspnoea—Pregabalin—epilepsy syndrome	2.91e-05	0.000174	CcSEcCtD
Reboxetine—Nausea—Oxcarbazepine—epilepsy syndrome	2.91e-05	0.000174	CcSEcCtD
Reboxetine—Skin disorder—Gabapentin—epilepsy syndrome	2.9e-05	0.000174	CcSEcCtD
Reboxetine—Somnolence—Pregabalin—epilepsy syndrome	2.9e-05	0.000174	CcSEcCtD
Reboxetine—Hyperhidrosis—Gabapentin—epilepsy syndrome	2.89e-05	0.000173	CcSEcCtD
Reboxetine—Tremor—Topiramate—epilepsy syndrome	2.89e-05	0.000173	CcSEcCtD
Reboxetine—Vomiting—Lamotrigine—epilepsy syndrome	2.89e-05	0.000173	CcSEcCtD
Reboxetine—Urticaria—Valproic Acid—epilepsy syndrome	2.86e-05	0.000172	CcSEcCtD
Reboxetine—Rash—Lamotrigine—epilepsy syndrome	2.86e-05	0.000172	CcSEcCtD
Reboxetine—Ill-defined disorder—Topiramate—epilepsy syndrome	2.86e-05	0.000171	CcSEcCtD
Reboxetine—Dermatitis—Lamotrigine—epilepsy syndrome	2.86e-05	0.000171	CcSEcCtD
Reboxetine—Abdominal pain—Valproic Acid—epilepsy syndrome	2.85e-05	0.000171	CcSEcCtD
Reboxetine—Body temperature increased—Valproic Acid—epilepsy syndrome	2.85e-05	0.000171	CcSEcCtD
Reboxetine—Anorexia—Gabapentin—epilepsy syndrome	2.85e-05	0.000171	CcSEcCtD
Reboxetine—Anaemia—Topiramate—epilepsy syndrome	2.85e-05	0.000171	CcSEcCtD
Reboxetine—Headache—Lamotrigine—epilepsy syndrome	2.84e-05	0.00017	CcSEcCtD
Reboxetine—Decreased appetite—Pregabalin—epilepsy syndrome	2.83e-05	0.00017	CcSEcCtD
Reboxetine—Agitation—Topiramate—epilepsy syndrome	2.83e-05	0.00017	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	2.81e-05	0.000169	CcSEcCtD
Reboxetine—Hypotension—Gabapentin—epilepsy syndrome	2.79e-05	0.000167	CcSEcCtD
Reboxetine—Nausea—Carbamazepine—epilepsy syndrome	2.79e-05	0.000167	CcSEcCtD
Reboxetine—Constipation—Pregabalin—epilepsy syndrome	2.79e-05	0.000167	CcSEcCtD
Reboxetine—Malaise—Topiramate—epilepsy syndrome	2.78e-05	0.000167	CcSEcCtD
Reboxetine—Vertigo—Topiramate—epilepsy syndrome	2.77e-05	0.000166	CcSEcCtD
Reboxetine—Syncope—Topiramate—epilepsy syndrome	2.76e-05	0.000166	CcSEcCtD
Reboxetine—Leukopenia—Topiramate—epilepsy syndrome	2.76e-05	0.000165	CcSEcCtD
Reboxetine—Palpitations—Topiramate—epilepsy syndrome	2.72e-05	0.000163	CcSEcCtD
Reboxetine—Loss of consciousness—Topiramate—epilepsy syndrome	2.71e-05	0.000162	CcSEcCtD
Reboxetine—Insomnia—Gabapentin—epilepsy syndrome	2.7e-05	0.000162	CcSEcCtD
Reboxetine—Nausea—Lamotrigine—epilepsy syndrome	2.7e-05	0.000162	CcSEcCtD
Reboxetine—Feeling abnormal—Pregabalin—epilepsy syndrome	2.69e-05	0.000161	CcSEcCtD
Reboxetine—Paraesthesia—Gabapentin—epilepsy syndrome	2.68e-05	0.000161	CcSEcCtD
Reboxetine—Gastrointestinal pain—Pregabalin—epilepsy syndrome	2.67e-05	0.00016	CcSEcCtD
Reboxetine—Dyspnoea—Gabapentin—epilepsy syndrome	2.67e-05	0.00016	CcSEcCtD
Reboxetine—Hypertension—Topiramate—epilepsy syndrome	2.66e-05	0.00016	CcSEcCtD
Reboxetine—Somnolence—Gabapentin—epilepsy syndrome	2.66e-05	0.000159	CcSEcCtD
Reboxetine—Hypersensitivity—Valproic Acid—epilepsy syndrome	2.66e-05	0.000159	CcSEcCtD
Reboxetine—Dyspepsia—Gabapentin—epilepsy syndrome	2.63e-05	0.000158	CcSEcCtD
Reboxetine—Chest pain—Topiramate—epilepsy syndrome	2.62e-05	0.000157	CcSEcCtD
Reboxetine—Anxiety—Topiramate—epilepsy syndrome	2.61e-05	0.000157	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	2.61e-05	0.000156	CcSEcCtD
Reboxetine—Decreased appetite—Gabapentin—epilepsy syndrome	2.6e-05	0.000156	CcSEcCtD
Reboxetine—Discomfort—Topiramate—epilepsy syndrome	2.59e-05	0.000155	CcSEcCtD
Reboxetine—Urticaria—Pregabalin—epilepsy syndrome	2.59e-05	0.000155	CcSEcCtD
Reboxetine—Asthenia—Valproic Acid—epilepsy syndrome	2.59e-05	0.000155	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	2.58e-05	0.000155	CcSEcCtD
Reboxetine—Abdominal pain—Pregabalin—epilepsy syndrome	2.58e-05	0.000155	CcSEcCtD
Reboxetine—Body temperature increased—Pregabalin—epilepsy syndrome	2.58e-05	0.000155	CcSEcCtD
Reboxetine—Dry mouth—Topiramate—epilepsy syndrome	2.57e-05	0.000154	CcSEcCtD
Reboxetine—Constipation—Gabapentin—epilepsy syndrome	2.56e-05	0.000153	CcSEcCtD
Reboxetine—Confusional state—Topiramate—epilepsy syndrome	2.54e-05	0.000152	CcSEcCtD
Reboxetine—Infection—Topiramate—epilepsy syndrome	2.5e-05	0.00015	CcSEcCtD
Reboxetine—Shock—Topiramate—epilepsy syndrome	2.47e-05	0.000148	CcSEcCtD
Reboxetine—Diarrhoea—Valproic Acid—epilepsy syndrome	2.47e-05	0.000148	CcSEcCtD
Reboxetine—Nervous system disorder—Topiramate—epilepsy syndrome	2.47e-05	0.000148	CcSEcCtD
Reboxetine—Feeling abnormal—Gabapentin—epilepsy syndrome	2.46e-05	0.000148	CcSEcCtD
Reboxetine—Tachycardia—Topiramate—epilepsy syndrome	2.45e-05	0.000147	CcSEcCtD
Reboxetine—Gastrointestinal pain—Gabapentin—epilepsy syndrome	2.44e-05	0.000147	CcSEcCtD
Reboxetine—Skin disorder—Topiramate—epilepsy syndrome	2.44e-05	0.000146	CcSEcCtD
Reboxetine—Hyperhidrosis—Topiramate—epilepsy syndrome	2.43e-05	0.000146	CcSEcCtD
Reboxetine—Hypersensitivity—Pregabalin—epilepsy syndrome	2.4e-05	0.000144	CcSEcCtD
Reboxetine—Anorexia—Topiramate—epilepsy syndrome	2.4e-05	0.000144	CcSEcCtD
Reboxetine—Dizziness—Valproic Acid—epilepsy syndrome	2.38e-05	0.000143	CcSEcCtD
Reboxetine—Urticaria—Gabapentin—epilepsy syndrome	2.38e-05	0.000142	CcSEcCtD
Reboxetine—Abdominal pain—Gabapentin—epilepsy syndrome	2.36e-05	0.000142	CcSEcCtD
Reboxetine—Body temperature increased—Gabapentin—epilepsy syndrome	2.36e-05	0.000142	CcSEcCtD
Reboxetine—Hypotension—Topiramate—epilepsy syndrome	2.35e-05	0.000141	CcSEcCtD
Reboxetine—Asthenia—Pregabalin—epilepsy syndrome	2.34e-05	0.00014	CcSEcCtD
Reboxetine—Vomiting—Valproic Acid—epilepsy syndrome	2.29e-05	0.000137	CcSEcCtD
Reboxetine—Insomnia—Topiramate—epilepsy syndrome	2.27e-05	0.000136	CcSEcCtD
Reboxetine—Rash—Valproic Acid—epilepsy syndrome	2.27e-05	0.000136	CcSEcCtD
Reboxetine—Dermatitis—Valproic Acid—epilepsy syndrome	2.27e-05	0.000136	CcSEcCtD
Reboxetine—Headache—Valproic Acid—epilepsy syndrome	2.26e-05	0.000135	CcSEcCtD
Reboxetine—Paraesthesia—Topiramate—epilepsy syndrome	2.26e-05	0.000135	CcSEcCtD
Reboxetine—Dyspnoea—Topiramate—epilepsy syndrome	2.24e-05	0.000134	CcSEcCtD
Reboxetine—Somnolence—Topiramate—epilepsy syndrome	2.24e-05	0.000134	CcSEcCtD
Reboxetine—Diarrhoea—Pregabalin—epilepsy syndrome	2.23e-05	0.000134	CcSEcCtD
Reboxetine—Dyspepsia—Topiramate—epilepsy syndrome	2.21e-05	0.000133	CcSEcCtD
Reboxetine—Hypersensitivity—Gabapentin—epilepsy syndrome	2.2e-05	0.000132	CcSEcCtD
Reboxetine—Decreased appetite—Topiramate—epilepsy syndrome	2.19e-05	0.000131	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Topiramate—epilepsy syndrome	2.17e-05	0.00013	CcSEcCtD
Reboxetine—Dizziness—Pregabalin—epilepsy syndrome	2.16e-05	0.000129	CcSEcCtD
Reboxetine—Constipation—Topiramate—epilepsy syndrome	2.15e-05	0.000129	CcSEcCtD
Reboxetine—Asthenia—Gabapentin—epilepsy syndrome	2.15e-05	0.000129	CcSEcCtD
Reboxetine—Nausea—Valproic Acid—epilepsy syndrome	2.14e-05	0.000128	CcSEcCtD
Reboxetine—Vomiting—Pregabalin—epilepsy syndrome	2.07e-05	0.000124	CcSEcCtD
Reboxetine—Feeling abnormal—Topiramate—epilepsy syndrome	2.07e-05	0.000124	CcSEcCtD
Reboxetine—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.06e-05	0.000123	CcSEcCtD
Reboxetine—Rash—Pregabalin—epilepsy syndrome	2.06e-05	0.000123	CcSEcCtD
Reboxetine—Dermatitis—Pregabalin—epilepsy syndrome	2.05e-05	0.000123	CcSEcCtD
Reboxetine—Diarrhoea—Gabapentin—epilepsy syndrome	2.05e-05	0.000123	CcSEcCtD
Reboxetine—Headache—Pregabalin—epilepsy syndrome	2.04e-05	0.000122	CcSEcCtD
Reboxetine—Urticaria—Topiramate—epilepsy syndrome	2e-05	0.00012	CcSEcCtD
Reboxetine—Abdominal pain—Topiramate—epilepsy syndrome	1.99e-05	0.000119	CcSEcCtD
Reboxetine—Body temperature increased—Topiramate—epilepsy syndrome	1.99e-05	0.000119	CcSEcCtD
Reboxetine—Dizziness—Gabapentin—epilepsy syndrome	1.98e-05	0.000119	CcSEcCtD
Reboxetine—Nausea—Pregabalin—epilepsy syndrome	1.94e-05	0.000116	CcSEcCtD
Reboxetine—Vomiting—Gabapentin—epilepsy syndrome	1.9e-05	0.000114	CcSEcCtD
Reboxetine—Rash—Gabapentin—epilepsy syndrome	1.89e-05	0.000113	CcSEcCtD
Reboxetine—Dermatitis—Gabapentin—epilepsy syndrome	1.88e-05	0.000113	CcSEcCtD
Reboxetine—Headache—Gabapentin—epilepsy syndrome	1.87e-05	0.000112	CcSEcCtD
Reboxetine—Hypersensitivity—Topiramate—epilepsy syndrome	1.85e-05	0.000111	CcSEcCtD
Reboxetine—Asthenia—Topiramate—epilepsy syndrome	1.8e-05	0.000108	CcSEcCtD
Reboxetine—Nausea—Gabapentin—epilepsy syndrome	1.78e-05	0.000106	CcSEcCtD
Reboxetine—Diarrhoea—Topiramate—epilepsy syndrome	1.72e-05	0.000103	CcSEcCtD
Reboxetine—Dizziness—Topiramate—epilepsy syndrome	1.66e-05	9.97e-05	CcSEcCtD
Reboxetine—Vomiting—Topiramate—epilepsy syndrome	1.6e-05	9.59e-05	CcSEcCtD
Reboxetine—Rash—Topiramate—epilepsy syndrome	1.59e-05	9.51e-05	CcSEcCtD
Reboxetine—Dermatitis—Topiramate—epilepsy syndrome	1.58e-05	9.5e-05	CcSEcCtD
Reboxetine—Headache—Topiramate—epilepsy syndrome	1.58e-05	9.45e-05	CcSEcCtD
Reboxetine—Nausea—Topiramate—epilepsy syndrome	1.49e-05	8.96e-05	CcSEcCtD
Reboxetine—CYP2D6—Metabolism—PFKL—epilepsy syndrome	1.05e-05	0.000267	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—SLC6A8—epilepsy syndrome	1.05e-05	0.000267	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—OPRD1—epilepsy syndrome	1.05e-05	0.000266	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—GNAO1—epilepsy syndrome	1.05e-05	0.000266	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—AKT3—epilepsy syndrome	1.04e-05	0.000263	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	1.04e-05	0.000263	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—CXCL12—epilepsy syndrome	1.03e-05	0.000262	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—BDKRB2—epilepsy syndrome	1.03e-05	0.000262	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—UPB1—epilepsy syndrome	1.02e-05	0.000259	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ATIC—epilepsy syndrome	1.02e-05	0.000259	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—NEU1—epilepsy syndrome	1.02e-05	0.000259	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	1.01e-05	0.000257	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—CNR1—epilepsy syndrome	1.01e-05	0.000257	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—PLCB1—epilepsy syndrome	1.01e-05	0.000256	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CCR7—epilepsy syndrome	1.01e-05	0.000255	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PDYN—epilepsy syndrome	1.01e-05	0.000255	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CHRM1—epilepsy syndrome	1.01e-05	0.000255	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—GRM1—epilepsy syndrome	1.01e-05	0.000255	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—HTR7—epilepsy syndrome	9.88e-06	0.000251	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—HSD17B4—epilepsy syndrome	9.82e-06	0.000249	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	9.63e-06	0.000244	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—NEU1—epilepsy syndrome	9.62e-06	0.000244	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—UPB1—epilepsy syndrome	9.62e-06	0.000244	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ATIC—epilepsy syndrome	9.62e-06	0.000244	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—HBEGF—epilepsy syndrome	9.6e-06	0.000243	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GBE1—epilepsy syndrome	9.49e-06	0.000241	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PPP1R3C—epilepsy syndrome	9.49e-06	0.000241	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—CDC42—epilepsy syndrome	9.46e-06	0.00024	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—GFAP—epilepsy syndrome	9.46e-06	0.00024	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—GAL—epilepsy syndrome	9.46e-06	0.00024	CbGpPWpGaD
Reboxetine—SLC6A2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	9.43e-06	0.000239	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—AKT3—epilepsy syndrome	9.42e-06	0.000239	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—GRM5—epilepsy syndrome	9.36e-06	0.000237	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CHRM3—epilepsy syndrome	9.36e-06	0.000237	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CASP2—epilepsy syndrome	9.36e-06	0.000237	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—HSD17B4—epilepsy syndrome	9.26e-06	0.000235	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—AVP—epilepsy syndrome	9.16e-06	0.000232	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	9.15e-06	0.000232	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	9.07e-06	0.00023	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PDXK—epilepsy syndrome	9.07e-06	0.00023	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	9.07e-06	0.00023	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ADK—epilepsy syndrome	9.07e-06	0.00023	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CERS1—epilepsy syndrome	9.07e-06	0.00023	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—FAR1—epilepsy syndrome	9.07e-06	0.00023	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CX3CR1—epilepsy syndrome	8.97e-06	0.000227	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GBE1—epilepsy syndrome	8.94e-06	0.000227	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PPP1R3C—epilepsy syndrome	8.94e-06	0.000227	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ASAH1—epilepsy syndrome	8.92e-06	0.000226	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	8.82e-06	0.000224	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CHRM2—epilepsy syndrome	8.8e-06	0.000223	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—BDKRB1—epilepsy syndrome	8.8e-06	0.000223	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CX3CL1—epilepsy syndrome	8.8e-06	0.000223	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—STXBP1—epilepsy syndrome	8.68e-06	0.00022	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—CDC42—epilepsy syndrome	8.59e-06	0.000218	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—GABBR1—epilepsy syndrome	8.56e-06	0.000217	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	8.5e-06	0.000215	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ALAD—epilepsy syndrome	8.45e-06	0.000214	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—NT5E—epilepsy syndrome	8.45e-06	0.000214	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	8.41e-06	0.000213	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ASAH1—epilepsy syndrome	8.4e-06	0.000213	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—AVP—epilepsy syndrome	8.32e-06	0.000211	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	8.3e-06	0.00021	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PNPO—epilepsy syndrome	8.3e-06	0.00021	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	8.3e-06	0.00021	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GAMT—epilepsy syndrome	8.3e-06	0.00021	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	8.25e-06	0.000209	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HRH3—epilepsy syndrome	8.2e-06	0.000208	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—STXBP1—epilepsy syndrome	8.18e-06	0.000207	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—OPRM1—epilepsy syndrome	8.08e-06	0.000205	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CACNA1A—epilepsy syndrome	8.07e-06	0.000205	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ALDH7A1—epilepsy syndrome	8.07e-06	0.000205	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—NT5E—epilepsy syndrome	7.97e-06	0.000202	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ALAD—epilepsy syndrome	7.97e-06	0.000202	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	7.89e-06	0.0002	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—CCR5—epilepsy syndrome	7.79e-06	0.000198	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ADSL—epilepsy syndrome	7.73e-06	0.000196	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CA4—epilepsy syndrome	7.71e-06	0.000196	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—QDPR—epilepsy syndrome	7.71e-06	0.000196	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	7.69e-06	0.000195	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CCR3—epilepsy syndrome	7.63e-06	0.000193	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—HTR2A—epilepsy syndrome	7.62e-06	0.000193	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	7.6e-06	0.000193	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	7.6e-06	0.000193	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GLUL—epilepsy syndrome	7.58e-06	0.000192	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	7.44e-06	0.000189	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	7.44e-06	0.000189	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NPY—epilepsy syndrome	7.43e-06	0.000188	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—ATP2A2—epilepsy syndrome	7.43e-06	0.000188	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	7.4e-06	0.000188	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ADSL—epilepsy syndrome	7.29e-06	0.000185	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—COX3—epilepsy syndrome	7.25e-06	0.000184	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—AGT—epilepsy syndrome	7.23e-06	0.000183	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	7.21e-06	0.000183	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—OXT—epilepsy syndrome	7.17e-06	0.000182	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CCL3—epilepsy syndrome	7.17e-06	0.000182	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HSPB1—epilepsy syndrome	7.17e-06	0.000182	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CXCL2—epilepsy syndrome	7.17e-06	0.000182	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CRH—epilepsy syndrome	7.17e-06	0.000182	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GLUL—epilepsy syndrome	7.15e-06	0.000181	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—CCR5—epilepsy syndrome	7.07e-06	0.000179	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	7.01e-06	0.000178	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	6.96e-06	0.000177	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—HTR2A—epilepsy syndrome	6.92e-06	0.000176	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	6.92e-06	0.000175	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PFKL—epilepsy syndrome	6.87e-06	0.000174	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	6.87e-06	0.000174	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	6.87e-06	0.000174	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	6.87e-06	0.000174	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	6.87e-06	0.000174	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	6.86e-06	0.000174	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—AQP1—epilepsy syndrome	6.76e-06	0.000171	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—PRKCB—epilepsy syndrome	6.68e-06	0.00017	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—TSC1—epilepsy syndrome	6.67e-06	0.000169	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PTK2B—epilepsy syndrome	6.67e-06	0.000169	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—AGT—epilepsy syndrome	6.57e-06	0.000167	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	6.56e-06	0.000166	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NTRK2—epilepsy syndrome	6.49e-06	0.000164	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—SST—epilepsy syndrome	6.49e-06	0.000164	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CCR2—epilepsy syndrome	6.49e-06	0.000164	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—DUSP6—epilepsy syndrome	6.43e-06	0.000163	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—AQP1—epilepsy syndrome	6.37e-06	0.000162	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—ADRA2A—epilepsy syndrome	6.35e-06	0.000161	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PLAT—epilepsy syndrome	6.32e-06	0.00016	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—UPB1—epilepsy syndrome	6.29e-06	0.000159	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—NEU1—epilepsy syndrome	6.29e-06	0.000159	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ATIC—epilepsy syndrome	6.29e-06	0.000159	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	6.18e-06	0.000157	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CHRM3—epilepsy syndrome	6.11e-06	0.000155	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	6.11e-06	0.000155	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—BDKRB2—epilepsy syndrome	6.1e-06	0.000155	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CXCL12—epilepsy syndrome	6.1e-06	0.000155	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—POMC—epilepsy syndrome	6.09e-06	0.000154	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—PRKCB—epilepsy syndrome	6.07e-06	0.000154	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	6.05e-06	0.000153	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—IL6ST—epilepsy syndrome	6.05e-06	0.000153	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CNR1—epilepsy syndrome	5.98e-06	0.000152	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—JUNB—epilepsy syndrome	5.98e-06	0.000152	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PLCB1—epilepsy syndrome	5.96e-06	0.000151	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GBE1—epilepsy syndrome	5.84e-06	0.000148	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	5.84e-06	0.000148	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HTR7—epilepsy syndrome	5.84e-06	0.000148	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	5.76e-06	0.000146	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	5.76e-06	0.000146	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HBEGF—epilepsy syndrome	5.67e-06	0.000144	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—AKT3—epilepsy syndrome	5.56e-06	0.000141	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—POMC—epilepsy syndrome	5.53e-06	0.00014	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	5.49e-06	0.000139	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—ADAM10—epilepsy syndrome	5.43e-06	0.000138	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—CCL2—epilepsy syndrome	5.41e-06	0.000137	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	5.35e-06	0.000136	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ALAD—epilepsy syndrome	5.21e-06	0.000132	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—NT5E—epilepsy syndrome	5.21e-06	0.000132	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—S100B—epilepsy syndrome	5.14e-06	0.00013	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—SOCS3—epilepsy syndrome	5.09e-06	0.000129	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CDC42—epilepsy syndrome	5.08e-06	0.000129	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ABCG2—epilepsy syndrome	4.98e-06	0.000126	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	4.97e-06	0.000126	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	4.97e-06	0.000126	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—AVP—epilepsy syndrome	4.91e-06	0.000125	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	4.86e-06	0.000123	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	4.86e-06	0.000123	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	4.83e-06	0.000122	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ADSL—epilepsy syndrome	4.76e-06	0.000121	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	4.7e-06	0.000119	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GLUL—epilepsy syndrome	4.67e-06	0.000118	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HES1—epilepsy syndrome	4.65e-06	0.000118	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	4.6e-06	0.000117	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	4.59e-06	0.000116	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	4.58e-06	0.000116	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	4.55e-06	0.000115	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—FYN—epilepsy syndrome	4.52e-06	0.000115	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—H2AFX—epilepsy syndrome	4.5e-06	0.000114	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MEF2C—epilepsy syndrome	4.5e-06	0.000114	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	4.36e-06	0.00011	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—YWHAZ—epilepsy syndrome	4.34e-06	0.00011	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NGF—epilepsy syndrome	4.3e-06	0.000109	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	4.29e-06	0.000109	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CCR5—epilepsy syndrome	4.18e-06	0.000106	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—AQP1—epilepsy syndrome	4.16e-06	0.000106	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	4.15e-06	0.000105	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	4.15e-06	0.000105	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—BCHE—epilepsy syndrome	4.13e-06	0.000105	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HTR2A—epilepsy syndrome	4.09e-06	0.000104	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	3.94e-06	9.99e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	3.91e-06	9.91e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PLCB1—epilepsy syndrome	3.9e-06	9.88e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—BCHE—epilepsy syndrome	3.89e-06	9.87e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—TSC2—epilepsy syndrome	3.89e-06	9.85e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—TH—epilepsy syndrome	3.88e-06	9.85e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—AGT—epilepsy syndrome	3.88e-06	9.84e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—APOE—epilepsy syndrome	3.8e-06	9.64e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	3.77e-06	9.55e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	3.77e-06	9.55e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—KDR—epilepsy syndrome	3.72e-06	9.45e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	3.71e-06	9.41e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	3.67e-06	9.31e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—TH—epilepsy syndrome	3.66e-06	9.28e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PRKCB—epilepsy syndrome	3.59e-06	9.09e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—IL6ST—epilepsy syndrome	3.57e-06	9.06e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—POMC—epilepsy syndrome	3.27e-06	8.28e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—HMOX1—epilepsy syndrome	3.24e-06	8.22e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CAT—epilepsy syndrome	3.2e-06	8.11e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CCL2—epilepsy syndrome	3.2e-06	8.1e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	3.07e-06	7.79e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	3.05e-06	7.74e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CAT—epilepsy syndrome	3.01e-06	7.64e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	2.99e-06	7.59e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	2.97e-06	7.54e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	2.93e-06	7.43e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GPX1—epilepsy syndrome	2.89e-06	7.33e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—FGF2—epilepsy syndrome	2.89e-06	7.32e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GPX1—epilepsy syndrome	2.72e-06	6.91e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.68e-06	6.81e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—RELA—epilepsy syndrome	2.68e-06	6.8e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MTOR—epilepsy syndrome	2.63e-06	6.67e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	2.55e-06	6.48e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—BCHE—epilepsy syndrome	2.54e-06	6.45e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—AGT—epilepsy syndrome	2.54e-06	6.43e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—APOE—epilepsy syndrome	2.48e-06	6.3e-05	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—AKT1—epilepsy syndrome	2.44e-06	6.19e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	2.43e-06	6.15e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CASP3—epilepsy syndrome	2.42e-06	6.13e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	2.4e-06	6.09e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—TH—epilepsy syndrome	2.39e-06	6.07e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—AGT—epilepsy syndrome	2.39e-06	6.06e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—JUN—epilepsy syndrome	2.35e-06	5.96e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—APOE—epilepsy syndrome	2.34e-06	5.94e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MMP9—epilepsy syndrome	2.29e-06	5.8e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—AKT1—epilepsy syndrome	2.22e-06	5.62e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—POMC—epilepsy syndrome	2.13e-06	5.41e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—SRC—epilepsy syndrome	2.11e-06	5.34e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—VEGFA—epilepsy syndrome	2.05e-06	5.2e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—POMC—epilepsy syndrome	2.01e-06	5.1e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	2e-06	5.06e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.97e-06	5e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ALB—epilepsy syndrome	1.95e-06	4.93e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.92e-06	4.86e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.83e-06	4.65e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.78e-06	4.52e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PTGS2—epilepsy syndrome	1.7e-06	4.32e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	1.6e-06	4.07e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.56e-06	3.96e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.53e-06	3.88e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.31e-06	3.33e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—AKT1—epilepsy syndrome	1.31e-06	3.32e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.2e-06	3.04e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.05e-06	2.66e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—AKT1—epilepsy syndrome	8.55e-07	2.17e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—AKT1—epilepsy syndrome	8.06e-07	2.04e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—AKT1—epilepsy syndrome	5.27e-07	1.34e-05	CbGpPWpGaD
